Cardiovascular and Renal Research
-
Encouraging news for those with chronic kidney disease
Posted on:
Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those…
Category:
-
Researchers to study link between cardiovascular disease and sleep apnoea
Posted on:
With a disturbing number of people losing their lives to heart disease each year, researchers have launched the first study of its kind using MRI technology to broaden our understanding of the link between cardiovascular disease and sleep apnoea. The project has been made possible following funding from the Ramsay Research Grant Program, and will…
-
Researchers develop test to identify the severity of kidney disease
Posted on:
We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive…
-
Masters players committed to the team, ignore heart health
Posted on:
Research from the University of Sydney and Royal North Shore Hospital provides insights into cardiac risk among footballers of masters age (35 years and older), an increasingly popular pastime. In what is believed to be the first study to assess cardiac knowledge and beliefs in this higher-risk amateur football group, researchers have found that one…
-
Study confirms deadly risk of COVID-19 for those with heart failure
Posted on:
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed…
-
New test for high blood pressure to save lives
Posted on:
Researchers and clinicians have welcomed Federal Government funding to improve the diagnosis and treatment of high blood pressure. The condition affects around 1 in 3 people in Australia, significantly increasing the risk of stroke, coronary heart disease, heart failure and chronic kidney disease. Men are more likely to have uncontrolled high blood pressure, with 1…
-
Life after cardiac arrest
Posted on:
Just over two years ago, Ian Hutchinson (Hutch) was cycling with a friend on Sydney’s northern beaches, taking part in an activity he regularly enjoyed with his mate. But that morning was to have a life-changing impact, with Hutch suffering a sudden cardiac arrest midway through the ride. It was only the quick thinking of…
Category:
-
Kolling researchers identifying COVID-19 impact on heart health
Posted on:
The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125…
-
Recognition for a remarkable career
Posted on:
Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice and…
-
Kolling researchers join global effort to reduce heart disease in women
Posted on:
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The Lancet women…
Category:
Copyright © 2026 Kolling Institute
All rights reserved